Last edition
News about "Phase 2 clinical trial"
Hengrui Pharma and Braveheart Bio have reported positive Phase 2 clinical trial results for investigational cardiac therapy HRS/BHB-1893 in patients with non-obstructive hypertrophic cardiomyopathy, demonstrating improvements in cardiac function, biomarkers and patient outcomes.
Phase 2 Clinical Trial | 12/05/2026 | By News Bureau
Hope Medicine Reports Positive Phase II Results for First-in-Class Endometriosis Drug
HMI-115 shows significant pain reduction without hormonal disruption, paving the way for global phase III trials.
Phase 2 Clinical Trial | 26/03/2026 | By News Bureau | 200
Inimmune Begins Phase 2 Trial of INI-2004 for Allergic Rhinitis
The randomised, placebo-controlled allergen chamber study will evaluate the safety and efficacy of Inimmune’s immunotherapy candidate INI-2004 in patients exposed to controlled ragweed allergens.
Phase 2 Clinical Trial | 08/01/2026 | By News Bureau | 183
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy